Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardiovascular Systems

Division of Cardiovascular Systems Inc.

Latest From Cardiovascular Systems

Number To Know…2,000

Up to 2,000 patients will be enrolled in Cardiovascular Systems' US pivotal study of its artherectomy system.

Cardiovascular Number to Know

Reverse Merger Success: Making It Out Of The Micro-Caps

Only about one-quarter of reverse mergers in recent years have market caps of more than $250 million. Of these, only about nine have become substantial companies since the reverse merger. Those that made it work say terrific assets, a track record of success and a strong management team are key to success.

BioPharmaceutical Business Strategies

The A-List: 2008's Trend Shaping Series A Financings

Despite a miserable economy, new company formation continues apace. In biotech, recapitalizations and structured deals featured prominently; in diagnostics, interest remains strong even if rounds in 2008 were down from last year's highs; in devices, small and regional VCs have filled the void left by brand-name investors.
BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (12/2008)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cardiovascular Systems Inc.
  • Senior Management
  • David L Martin, Pres. & CEO
    Laurence L Betterley, CFO
    Michael J Kallok, PhD, CSO
    Paul Tyska, VP, Bus. Dev.
  • Contact Info
  • Cardiovascular Systems
    Phone: (877) 274-0360
    651 Campus Dr.
    St. Paul, MN 55112